Antihistamines, part II: Long-term adverse eff ects?

Where's the evidence?" (September 2019), reviewed recently published data suggesting that antihistamine product use may be increasing for the treatment of common cold symptoms. Because recent recommendations and regulations have decreased the use of cough/cold products in the pediatric pop...

Full description

Saved in:
Bibliographic Details
Published inInfectious diseases in children Vol. 32; no. 11; p. 9
Main Author Bell, Edward A
Format Journal Article
LanguageEnglish
Published Thorofare SLACK INCORPORATED 01.11.2019
Subjects
Adults
Antidepressants
Cognition & reasoning
Dementia
Drug use
Pediatrics
Pharmacology
Pharmacy
Population
Psychotropic drugs
Researchers
Studies
Iowa
United Kingdom > UK
United States > US
England
Des Moines Iowa
Online AccessGet full text

Cover

More Information
Summary:Where's the evidence?" (September 2019), reviewed recently published data suggesting that antihistamine product use may be increasing for the treatment of common cold symptoms. Because recent recommendations and regulations have decreased the use of cough/cold products in the pediatric population, pediatric health care providers may be turning to antihistamine-based products instead. First-generation antihistamines are often referred to as "sedating antihistamines." [...]generation antihistamines (eg, cetirizine, loratadine), considered nonsedating because of their relative lack of CNS penetration, are commonly prescribed to children and adults for allergic conditions.
ISSN:1044-9779